Concepedia

Paul H. Berg

PH

18

Publications

1.5K

Citations

14

H-Index

1996

Active since

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (United Kingdom)

Orlando Clinical Research Center

Indiana University – Purdue University Indianapolis

Purdue University West Lafayette

Paul H. Berg is an author at Eli Lilly (United States) specializing in medicine, social sciences, and schizophrenia.

Top concepts

MedicineHealthBiologyGeneticsPsychosisPsychiatryPsychologyAntibioticsMicrobiologyPharmacology

Publications per year

1996–2023

18

Publications

18

Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy

James R. Voelker, Paul H. Berg, Matthew J. Sheetz et al. · Journal of the American Society of Nephrology · 2016 · 264 citations

Lasmiditan is an effective acute treatment for migraine

Bernice Kuca, Stephen D. Silberstein, Linda Wietecha et al. · Neurology · 2018 · 260 citations · Full text

Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation

Stephen J. Nicholls, Steven E. Nissen, Cynthia Griggs Fleming et al. · JAMA · 2023 · 161 citations · Full text

Olanzapine Versus Ziprasidone: Results of a 28-Week Double-Blind Study in Patients With Schizophrenia

Alan Breier, Paul H. Berg, Jogin H. Thakore et al. · American Journal of Psychiatry · 2005 · 154 citations

Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis

Joerg Czekalla, Charles M. Beasley, Mary Anne Dellva et al. · The Journal of Clinical Psychiatry · 2001 · 119 citations

Rows per page

1–5 of 18